Cargando…
The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science
In the post-genomic era, it has become evident that genetic changes alone are not sufficient to understand most disease processes including pancreatic cancer. Genome sequencing has revealed a complex set of genetic alterations in pancreatic cancer such as point mutations, chromosomal losses, gene am...
Autores principales: | Ansari, Daniel, Aronsson, Linus, Sasor, Agata, Welinder, Charlotte, Rezeli, Melinda, Marko-Varga, György, Andersson, Roland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998064/ https://www.ncbi.nlm.nih.gov/pubmed/24708694 http://dx.doi.org/10.1186/1479-5876-12-87 |
Ejemplares similares
-
Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018) -
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
por: Bauden, Monika, et al.
Publicado: (2017) -
Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker
por: Byrling, Johannes, et al.
Publicado: (2020) -
Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue
por: Zhou, Qimin, et al.
Publicado: (2019) -
Clusterwise Peak Detection and Filtering Based on
Spatial Distribution To Efficiently Mine Mass Spectrometry Imaging
Data
por: Eriksson, Jonatan O., et al.
Publicado: (2019)